IMPACT SCORE JOURNAL RANKING CONFERENCE RANKING Conferences Journals Workshops Seminars SYMPOSIUMS MEETINGS BLOG LaTeX 5G Tutorial Free Tools

Search About Journals, Conferences, and Book Series

EJNMMI Radiopharmacy and Chemistry

Impact, Factor and Metrics, Impact Score, Ranking, h-index, SJR, Rating, Publisher, ISSN, and More

Last Updated on June 27, 2025

Impact Score

2024-2025

3.09

h-Index

2024-2025

 32

Rank

2024-2025

 5810

SJR

2024-2025

 0.888

Note: The impact score or impact index shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.

Important Metrics and Factor

Title EJNMMI Radiopharmacy and Chemistry
Abbreviation EJNMMI Radiopharm. Chem.
Publication Type Journal
Subject Area, Categories, Scope Analytical Chemistry (Q1); Radiology, Nuclear Medicine and Imaging (Q1); Pharmacology (Q2); Pharmacology (medical) (Q2)
h-index 32
Overall Rank/Ranking 5810
SCImago Journal Rank (SJR) 0.888
Impact Score 3.09
Publisher Springer Science and Business Media Deutschland GmbH
Country Switzerland
ISSN 2365421X
Best Quartile Q1
Coverage History 2016-2025




About EJNMMI Radiopharmacy and Chemistry


EJNMMI Radiopharmacy and Chemistry is a journal covering the technologies/fields/categories related to Analytical Chemistry (Q1); Radiology, Nuclear Medicine and Imaging (Q1); Pharmacology (Q2); Pharmacology (medical) (Q2). It is published by Springer Science and Business Media Deutschland GmbH. The overall rank of EJNMMI Radiopharmacy and Chemistry is 5810. According to SCImago Journal Rank (SJR), this journal is ranked 0.888. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 32. The best quartile for this journal is Q1.

The ISSN of EJNMMI Radiopharmacy and Chemistry journal is 2365421X. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. EJNMMI Radiopharmacy and Chemistry is cited by a total of 416 articles during the last 3 years (Preceding 2024).


EJNMMI Radiopharmacy and Chemistry Impact IF 2024-2025


The Impact IF 2024 of EJNMMI Radiopharmacy and Chemistry is 3.09, which is computed in 2025 as per its definition. EJNMMI Radiopharmacy and Chemistry IF is decreased by a factor of 0.5 and approximate percentage change is -13.93% when compared to preceding year 2023, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

EJNMMI Radiopharmacy and Chemistry Impact IF 2025 Prediction


Impact IF 2024 of EJNMMI Radiopharmacy and Chemistry is 3.09. If the same downward trend persists, Impact IF may fall in 2025 as well.


Impact IF Trend


Year wise Impact IF of EJNMMI Radiopharmacy and Chemistry. Based on Scopus data.


Year Impact IF
2025/2026 Coming Soon
2024 3.09
2023 3.59
2022 4.06
2021 5.10
2020 3.13
2019 2.20
2018 2.14
2017 2.46
2016 0.00

EJNMMI Radiopharmacy and Chemistry h-index


  Table Setting

EJNMMI Radiopharmacy and Chemistry has an h-index of 32. It means 32 articles of this journal have more than 32 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.




EJNMMI Radiopharmacy and Chemistry ISSN


The ISSN of EJNMMI Radiopharmacy and Chemistry is 2365421X. ISSN stands for International Standard Serial Number.

An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.

Table Setting

EJNMMI Radiopharmacy and Chemistry Rank and SCImago Journal Rank (SJR)


The overall rank of EJNMMI Radiopharmacy and Chemistry is 5810. According to SCImago Journal Rank (SJR), this journal is ranked 0.888. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.

SJR of EJNMMI Radiopharmacy and Chemistry by Year


Year SJR
2025/2026 Coming Soon
2024 0.888
2023 0.869
2022 0.972
2021 0.447
2020
2019
2018
2017
2016

Ranking of EJNMMI Radiopharmacy and Chemistry by Year


Year Ranking
2025/2026 Coming Soon
2024 5810
2023 5509
2022 4405
2021 11046
2020 33186
2019 30788
2018 32235
2017 32996
2016 32702

EJNMMI Radiopharmacy and Chemistry Publisher


Table Setting

EJNMMI Radiopharmacy and Chemistry is published by Springer Science and Business Media Deutschland GmbH. It's publishing house is located in Switzerland. Coverage history of this journal is as following: 2016-2025. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.


Call For Papers


Visit the official website of the journal/conference to check the further details about the call for papers.


Abbreviation


The IS0 4 standard abbreviation of EJNMMI Radiopharmacy and Chemistry is EJNMMI Radiopharm. Chem.. This abbreviation ('EJNMMI Radiopharm. Chem.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.

ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.


How to publish in EJNMMI Radiopharmacy and Chemistry


If your research field is/are related to Analytical Chemistry (Q1); Radiology, Nuclear Medicine and Imaging (Q1); Pharmacology (Q2); Pharmacology (medical) (Q2), then please visit the official website of this journal.


Acceptance Rate


The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.

  • The demand or interest of researchers/scientists in publishing in a specific Journal/Conference.
  • Peer review complexity and timeline.
  • The mix of unsolicited and invited submissions.
  • The time it takes from manuscript submission to final publication.
  • And Many More.

It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.

The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.



Frequently Asked Questions (FAQs)


What's the latest impact IF of the EJNMMI Radiopharmacy and Chemistry?

EJNMMI Radiopharmacy and Chemistry latest impact IF is 3.09. It's evaluated in the year 2024. The highest and the lowest impact IF or impact score of this journal are 5.10 (2021) and 0.00 (2016), respectively, in the last 9 years. Moreover, its average IS is 2.86 in the previous 9 years.


What's the SCImago Journal Rank (SJR) of the EJNMMI Radiopharmacy and Chemistry?

The EJNMMI Radiopharmacy and Chemistry has an SJR (SCImago Journal Rank) of 0.888, according to the latest data. It is computed in the year 2025. In the past 9 years, this journal has recorded a range of SJR, with the highest being 0.972 in 2022 and the lowest being in 2020. Furthermore, the average SJR of the EJNMMI Radiopharmacy and Chemistry over the previous 9-year period stands at 2.86.


What's the latest h-index of the EJNMMI Radiopharmacy and Chemistry?

The latest h-index of the EJNMMI Radiopharmacy and Chemistry is 32.


Who's the publisher of the EJNMMI Radiopharmacy and Chemistry?

The EJNMMI Radiopharmacy and Chemistry is published by the Springer Science and Business Media Deutschland GmbH, with its country of publication being the Switzerland.


What's the current ranking of the EJNMMI Radiopharmacy and Chemistry?

The EJNMMI Radiopharmacy and Chemistry is currently ranked 5810 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 9 years, this journal has experienced varying rankings, reaching its highest position of 4405 in 2022 and its lowest position of 33186 in 2020.


What's the abbreviation or short name for the EJNMMI Radiopharmacy and Chemistry?

The standard ISO4 abbreviation for the EJNMMI Radiopharmacy and Chemistry is EJNMMI Radiopharm. Chem..


Is the "EJNMMI Radiopharmacy and Chemistry" classified as a Journal, Conference and Proceedings, Trade Journal or Book Series?

EJNMMI Radiopharmacy and Chemistry is classified as a journal that the Springer Science and Business Media Deutschland GmbH publishes.


What's the scope or major areas of the EJNMMI Radiopharmacy and Chemistry?

The EJNMMI Radiopharmacy and Chemistry encompasses the following areas:

  • Analytical Chemistry
  • Radiology, Nuclear Medicine and Imaging
  • Pharmacology
  • Pharmacology (medical)

For a more comprehensive understanding of its scope, check the official website of this journal.


What's the ISSN of the EJNMMI Radiopharmacy and Chemistry?

The EJNMMI Radiopharmacy and Chemistry is assigned the following International Standard Serial Numbers (ISSN): 2365421X.


What's the best quartile of the EJNMMI Radiopharmacy and Chemistry?

The best quartile for the EJNMMI Radiopharmacy and Chemistry is Q1 (2024).


What's the coverage history of the EJNMMI Radiopharmacy and Chemistry?

The EJNMMI Radiopharmacy and Chemistry coverage history can be summarized as follows: 2016-2025.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/



Impact Score, h-Index, and Other Important Details of These Journals, Conferences, and Books


Journal/Conference/Workshop/Book Title Type Ranking Publisher h-index Impact Score
Indian Journal of Plastic Surgery journal 30965 Georg Thieme Verlag 44 0.46
SPE Production and Operations Symposium, Proceedings conference and proceedings 15907 21 0.00
Criminal Justice Review journal 10284 SAGE Publications Inc. 46 1.91
Journal of International Financial Management and Accounting journal 1434 Wiley-Blackwell Publishing Ltd 50 10.53
Transnational Corporations journal 13970 UNCTAD United Nations Conference on Trade and Development 30 1.63
Studies in Continuing Education journal 4850 Routledge 44 3.35
Exploration Geophysics journal 18330 Taylor and Francis Ltd. 52 0.90
Asian Textile Journal trade journal 25375 G P S Kwatra 11 0.08
Epigenetics journal 4304 Taylor and Francis Ltd. 117 3.37
Proteomics - Clinical Applications journal 8540 Wiley-VCH Verlag 67 2.59

Check complete list




Year wise Impact Score (IS) of EJNMMI Radiopharmacy and Chemistry

Impact Score Table

Year Impact Score (IS)
2025/2026 Coming Soon
2024 3.09
2023 3.59
2022 4.06
2021 5.10
2020 3.13
2019 2.20
2018 2.14
2017 2.46
2016 0.00



Top Journals/Conferences in Analytical Chemistry

JACS Au
American Chemical Society | United States

Trends in Environmental Analytical Chemistry
Elsevier B.V. | Netherlands

TrAC - Trends in Analytical Chemistry
Elsevier B.V. | Netherlands

Current Opinion in Chemical Biology
Elsevier Ltd | United Kingdom

Progress in Nuclear Magnetic Resonance Spectroscopy
Elsevier B.V. | Netherlands

Food Chemistry
Elsevier Ltd | United Kingdom

Molecular and Cellular Proteomics
American Society for Biochemistry and Molecular Biology Inc. | United States

Current Opinion in Electrochemistry
Elsevier B.V. | Netherlands

Separation and Purification Technology
Elsevier B.V. | Netherlands

Analytical Chemistry
American Chemical Society | United States

See All

Top Journals/Conferences in Radiology, Nuclear Medicine and Imaging

JACC: Cardiovascular Imaging
Elsevier Inc. | United States

Cancer Treatment Reviews
W.B. Saunders Ltd | United Kingdom

Radiology
Radiological Society of North America Inc. | United States

European urology oncology
Elsevier B.V. | Netherlands

Medical Image Analysis
Elsevier B.V. | Netherlands

Radiology: Artificial Intelligence
Radiological Society of North America Inc. | United States

npj Breast Cancer
Nature Publishing Group | United Kingdom

Investigative Radiology
Lippincott Williams and Wilkins Ltd. | United States

European Journal of Nuclear Medicine and Molecular Imaging
Springer Verlag | Germany

Meta-Radiology
KeAi Publishing Communications Ltd. | China

See All

Top Journals/Conferences in Pharmacology

Nature Reviews Drug Discovery
Nature Research | United Kingdom

Pharmacological Reviews
Elsevier Inc. | United States

Drug Resistance Updates
Churchill Livingstone | United Kingdom

Journal for ImmunoTherapy of Cancer
BMJ Publishing Group | United Kingdom

Annual Review of Pharmacology and Toxicology
Annual Reviews Inc. | United States

Molecular Therapy
Cell Press | United States

Pharmacology and Therapeutics
Elsevier Inc. | United States

Trends in Pharmacological Sciences
Elsevier Ltd | United Kingdom

Acta Pharmaceutica Sinica B
Chinese Academy of Medical Sciences | China

Theranostics
Ivyspring International Publisher | Australia

See All

Top Journals/Conferences in Pharmacology (medical)

Drug Resistance Updates
Churchill Livingstone | United Kingdom

Pharmacology and Therapeutics
Elsevier Inc. | United States

Drugs
| Switzerland

Journal of Biomedical Science
BioMed Central Ltd | United Kingdom

npj Breast Cancer
Nature Publishing Group | United Kingdom

Alimentary Pharmacology and Therapeutics
John Wiley and Sons Inc | United Kingdom

American Journal of Transplantation
Elsevier B.V. | Netherlands

Acta Pharmacologica Sinica
Springer Nature | United Kingdom

BioDrugs
| Switzerland

npj Vaccines
Nature Publishing Group | United Kingdom

See All